Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127030241 | 12703024 | 1 | I | 20160805 | 20160818 | 20160831 | 20160831 | EXP | JP-PFIZER INC-2016392897 | PFIZER | 74.00 | YR | F | Y | 0.00000 | 20160831 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127030241 | 12703024 | 1 | PS | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, DAILY | U | 19787 | 5 | MG | |||||||
| 127030241 | 12703024 | 2 | SS | TRAMAL OD | TRAMADOL | 1 | Oral | 75 MG, DAILY | N | 0 | 75 | MG | ORODISPERSIBLE TABLET | ||||||
| 127030241 | 12703024 | 3 | SS | TRAMAL OD | TRAMADOL | 1 | Oral | 125 MG, DAILY | N | 0 | 125 | MG | ORODISPERSIBLE TABLET | ||||||
| 127030241 | 12703024 | 4 | SS | CALONAL | ACETAMINOPHEN | 1 | Oral | 6 DF, DAILY | U | 0 | 6 | DF | TABLET | ||||||
| 127030241 | 12703024 | 5 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 1 DF, DAILY | U | 0 | 1 | DF | CAPSULE | ||||||
| 127030241 | 12703024 | 6 | SS | MUCOSOLVAN | AMBROXOL HYDROCHLORIDE | 1 | Oral | 3 DF, 3X/DAY | U | 0 | 3 | DF | TABLET | TID | |||||
| 127030241 | 12703024 | 7 | SS | MUCOSTA | REBAMIPIDE | 1 | Oral | 3 DF, 3X/DAY | U | 0 | 3 | DF | TABLET | TID | |||||
| 127030241 | 12703024 | 8 | SS | DEPAS | ETIZOLAM | 1 | Oral | 1 DF, DAILY | U | 0 | 1 | DF | TABLET | ||||||
| 127030241 | 12703024 | 9 | SS | LIVALO | PITAVASTATIN CALCIUM | 1 | Oral | 1 DF, DAILY | U | 0 | 1 | DF | TABLET | ||||||
| 127030241 | 12703024 | 10 | SS | LAC B | BIFIDOBACTERIUM SPP. | 1 | Oral | 90 MG, DAILY | U | 0 | 90 | MG | |||||||
| 127030241 | 12703024 | 11 | SS | MEILAX | ETHYL LOFLAZEPATE | 1 | Oral | 1 DF, DAILY | U | 0 | 1 | DF | TABLET | ||||||
| 127030241 | 12703024 | 12 | SS | MYSLEE | ZOLPIDEM TARTRATE | 1 | Oral | 10 MG, DAILY | U | 0 | 10 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127030241 | 12703024 | 2 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127030241 | 12703024 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127030241 | 12703024 | Anorectal disorder | |
| 127030241 | 12703024 | Constipation | |
| 127030241 | 12703024 | Neurogenic bladder | |
| 127030241 | 12703024 | Urinary retention |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127030241 | 12703024 | 2 | 20160729 | 20160803 | 0 | |
| 127030241 | 12703024 | 3 | 20160804 | 20160806 | 0 |